India's third largest pharmaceutical company Cipla is targeting 10-12 percent growth in the domestic market in next two to three years, its newly elected Managing Director and Global Chief Executive Umang Vohra said.
first published: Sep 28, 2016 04:41 pm
A collection of the most-viewed Moneycontrol videos.
